Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Midazolam”

232 trials

Showing 20 of 232 results

Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT01182077
What this trial is testing

Assess Drug Interaction of ASP015K and Midazolam

Who this might be right for
HealthyPharmacokinetics of ASP015K and Midazolam
Astellas Pharma Inc 30
Early research (Phase 1)Study completedNCT05942365
What this trial is testing

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

Who this might be right for
Drug Drug InteractionWarfarinMidazolam
Guangdong Raynovent Biotech Co., Ltd 28
Early research (Phase 1)Study completedNCT05594615
What this trial is testing

Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects

Who this might be right for
COVID-19
Enanta Pharmaceuticals, Inc 24
Early research (Phase 1)Study completedNCT03311841
What this trial is testing

Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

Who this might be right for
Renal Insufficiency
Merck Sharp & Dohme LLC 32
Early research (Phase 1)Study completedNCT01944683
What this trial is testing

Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Who this might be right for
Heart Failure
Acorda Therapeutics 22
Early research (Phase 1)Study completedNCT01162486
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Johns Hopkins University 37
Early research (Phase 1)Study completedNCT05738291
What this trial is testing

A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 67
Early research (Phase 1)Study completedNCT00790114
What this trial is testing

Determine the Effect of Multiple Doses of AZD7325, CYP Study

Who this might be right for
Healthy Volunteer
AstraZeneca 24
Early research (Phase 1)Study completedNCT01756781
What this trial is testing

A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.

Who this might be right for
Healthy
Pfizer 26
Early research (Phase 1)Study completedNCT02370615
What this trial is testing

Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam

Who this might be right for
Japanese Healthy Adult Males
Takeda 34
Early research (Phase 1)Study completedNCT04958226
What this trial is testing

Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumour
AstraZeneca 21
Early research (Phase 1)Study completedNCT04718740
What this trial is testing

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 33
Early research (Phase 1)Study completedNCT02617810
What this trial is testing

Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 18
Early research (Phase 1)Study completedNCT04829773
What this trial is testing

Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 48
Early research (Phase 1)Study completedNCT05492318
What this trial is testing

Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

Who this might be right for
Drug-Drug InteractionHeathy Volunteer
Italfarmaco 26
Early research (Phase 1)Study completedNCT03363815
What this trial is testing

Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

Who this might be right for
Heathy Volunteer
Celgene 56
Early research (Phase 1)Study completedNCT03988907
What this trial is testing

A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants

Who this might be right for
Spinal Muscular Atrophy
Hoffmann-La Roche 35
Early research (Phase 1)Study completedNCT02456844
What this trial is testing

Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 24
Early research (Phase 1)Study completedNCT01287598
What this trial is testing

BAY73-4506 Probe Substrate Study

Who this might be right for
Neoplasms
Bayer 41
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation